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Ultrasound guided biopsyAbstract Background: Medical thoracoscopy increases the diagnostic yield in patients with undi-
agnosed pleural effusion. Ultrasound guided pleural biopsies are safe procedures with high diagnos-
tic yields.
Objective: To compare safety and efﬁcacy of medical thoracoscopic versus ultrasound guided
transthoracic needle biopsy in the diagnosis of pleural lesions.
Patients and methods: 40 patients with undiagnosed pleural lesions were divided into 2 groups.
After clinical, radiological examination and laboratory investigations; pleural biopsies were taken
by ultrasound guided needle biopsy and medical thoracoscopy in group I and II respectively.
Results: Complications in group I were in the form of pain in 2 patients (10%), hemoptysis in 1
(5%), while complications in group II were pain in 4 (20%), failure of the lung to expand in 5
(25%), pneumothorax in 5 (25%) and wound infection in 3 patients (15%).
Final histopathological diagnosis in group I was parapneumonic effusion in 3 patients (15%),
inﬂammatory lung lesion in 1 (5%), pleural ﬁbroma in 2 (10%), malignant mesothelioma in 4
(20%), sarcoma in 1 (5%), adenocarcinoma in 1 (5%), squamous cell carcinoma in 4 (20%), and
metastatic adenocarcinoma in 1 (5%). Final histopathological diagnosis in group II was pleural
TB in 4 patients (20%), inﬂammatory lung lesions in 2 (10%), malignant mesothelioma in 6
(30%), adenocarcinoma in 5 (25%), and metastatic adenocarcinoma in 2 (10%). The diagnosed
cases were 17 (85%) and 19 (95%) in groups I and II respectively.
Conclusions: Medical thoracoscopy is an important diagnostic method for the diagnosis of undi-
agnosed pleural effusion while it is concluded that US guided pleural biopsy is more useful in cases
of pleural lesions without effusion.
 2015 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Pleural effusion is deﬁned as the abnormal collection of ﬂuid in
the pleural space resulting from excessive ﬂuid production or
decreased absorption [1]. Pleural effusion is one of the most
common clinical conditions in pulmonology clinics and in hos-
pitals. The relative annual incidence of pleural effusion is esti-
mated to be 320 per 100,000 people in industrialized countries
[2].
Ultrasound (US) has found a ﬁrm place in chest medicine
as an aid for assessing pleural effusions at the bedside [3]. This
development was facilitated by the advent of affordable, light-
weight and mobile US units. US can also visualize solid lesions
arising from the pleura, chest wall and anterior mediastinum,
and even lung tumors and consolidations are detected without
difﬁculty provided that they extend to the parietal pleura. US
is an ideal tool to assist with biopsy procedures. It can fre-
quently replace Computed Tomographic (CT) guidance at
much lower cost [4].
Medical thoracoscopy is a minimally invasive procedure
performed by the pneumologist in an endoscopy suite; it is
much less invasive requiring only local anesthesia with con-
scious sedation and only one or two points of entry. It also
allows for basic diagnostic (undiagnosed pleural ﬂuid or pleu-
ral thickening) and therapeutic procedures (pleurodesis) to be
performed safely [5].
Objective
To compare safety and efficacy of medical thoracoscopic ver-
sus ultrasound guided transthoracic needle biopsy in diagnosis
of pleural lesions.
Patients and methods
This study was carried out in Chest and Radiology Depart-
ments, Faculty of Medicine, Tanta University Hospitals from
April 2013 to October 2014. This study was approved by
Research Ethics Committee, Faculty of Medicine, Tanta
University; an informed written consent was taken from each
patient. Forty patients with undiagnosed pleural lesions were
enrolled in this study; the patients were divided into two
groups: group I included 20 patients in whom Tru-cut needle
biopsy was carried out guided by ultrasonography for the diag-
nosis of pleural lesions. Group II included 20 patients in whom
medical thoracoscopy was performed for the diagnosis of pleu-
ral lesions by biopsy taking.
Inclusion criteria
 Patients with evidence of exudative pleural effusion
(according to Light’s criteria) [6] for which a speciﬁc diag-
nosis could not be determined by cytological, chemical
and bacteriological methods. Also, patients with peripheral
pleural lesion that was accessible by ultrasound guided nee-
dle biopsy was eligible for this study.
 Lesions involving or abutting the pleura equal to or more
than 20 mm in diameter on US were sampled.Exclusion criteria
 Cardiovascular instability.
 Lack of patient cooperation, e.g. intractable cough, inabil-
ity to remain motionless or altered consciousness.
 Bleeding diathesis (international normalized ratio (INR)
<1.3 or platelet count of <50,000 per mm3), patients on
anticoagulant therapy (oral anticoagulants should be
stopped before the procedure for at least 72 h).
 Contralateral pneumonectomy.
 Borderline respiratory failure and patients on mechanical
ventilation.
 Severe chronic obstructive pulmonary disease (FEV1 < 1
liter or <35% predicted).
 Pyogenic cutaneous lesion.
 Empyema.
 Liver failure or renal failure.
 A relative contraindication in cases of extensive pleural
adhesions to do medical thoracoscopy [7].
All patients were subjected to the following
(1) Thorough history taking and clinical examination.
(2) Chest X-ray (postro-anterior and lateral views) before
and after the procedure.
(3) Recent Computed Tomography (CT) of the chest with
contrast.
(4) Laboratory studies including coagulation proﬁle
(including bleeding and clotting times, prothrombin
time and activity)
(5) Preoperative evaluation: arterial blood gases (ABG),
electrocardiogram (ECG), and pulmonary function tests
if clinically indicated.
(6) Color Doppler ultrasound in suspected vascular lesions.
(7) Clinical and radiological follow up of patients over
1 week after the procedure to detect the occurrence of
any complications.
(8) The biopsy guided by ultrasonography in group I was
carried out using Tru-cut needle biopsy in different
calibers.
(9) The biopsy samples were sent for histopathological
examination. Ultrasound guided transthoracic pleural
biopsy was performed under local anesthesia and was
performed without sedation as much as possible.
Procedure of ultrasound guided pleural needle biopsy in group I
The procedure was done using ultrasound (Mindray DT 20
Italy), patient was kept fasting at least 6 h before biopsy, a
sterile ﬁeld was created. The same transducers used for diag-
nostic ultrasonography (Logic GA 400) could be used for
biopsy: convex array or sector scanning transducers with a fre-
quency of 2–5 MHz which allows scanning through intercostal
spaces. The presence of an ultrasound window with the
absence of bone or air overlying the lesion and the absence
of any vital organs along the needle path was necessary for
biopsy. The angle of needle entry and the depth of the lesion
could be determined.
Table 1 Characteristics of patients in the two groups.
Parameter Group I
(N= 20)
Group II
(N= 20)
t or
X2
P
Age (years)
Mean ± SD
61.75
± 12.33
49.85
± 10.5
3.286t 0.002*
Gender
Male n (%) 13 (65%) 12 (60%)
0.000x 1.00
Female n (%) 7 (35%) 8 (40%)
Smoking history
Non smoker n (%) 8 (40%) 11 (55%)
1.474x 0.478Ex-smoker n (%) 6 (30%) 3 (15%)
Current smoker n (%) 6 (30%) 6 (30%)
* P< 0.05,
t t test,
x Chi-square.
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position, with the subject’s arms folded across the chest and
supported by a bedside table. Local anesthesia in the form of
subcutaneous injection of xylocaine 2%. Percutaneous
ultrasound-guided pleural biopsy was done with a 14 or 16
gauge cutting needle (Quistello (MN) – Italy). Cores were
obtained by using a biopsy gun.
The introducer was advanced into the rib interspace, the
patient should hold his breath as it was advanced into the tar-
get lesion. Resistance could be encountered when entering the
lesion, whenever the introducer needle was opened to the
atmosphere; the patient was again asked to hold breath. The
stylet was removed, and the cutting needle was inserted,
adjusted to the desired depth if applicable. The cutting needle
should be oriented with the cutting aspect directed caudally to
avoid laceration of intercostal vessels and nerves. The needle
should be immediately discharged after insertion. Specimens
were harvested until yielding at least three macroscopically sat-
isfactory specimens for histopathological examination (trans-
ported in formalin 10%). Chest X-ray was done for all
patients. All patients were observed for at least 1 h before dis-
charge and complications were noted.
Thoracoscopy procedure in group II
Thoracoscopic procedure was done using rigid thoracoscopy
(Karl Storz; Tuttlingen, Germany) and its equipment and
videoscopy unit (camera (Karl Storz Endoskope Telecam Pal
20211020), light source (Pentax LH-150 PC). The patient
was lying down with the diseased site being the upper most
with continuous monitoring of pulse, blood pressure, oxygen
saturation using a portable monitor, and oxygen supply was
connected to the patient. A rolled-up sheet was placed under
the patient’s thorax to spread apart all the intercostal spaces
on the exposed side of the chest wall.
The operator was in front of the patient, the assistant was
usually behind the patient, the instruments were within the
reach of the operator and the assistant, and the monitor was
placed at the head of the operating table. Anesthesia with
Lidocaine 2% about 30–40 mL was given to anesthetize the
skin, subcutaneous tissue and muscles till pleura, along with
I.V. agent for sedation, analgesia, and amnesia (5 mg Droperi-
dol, 5–10 mg Pethidine). A needle thoracentesis with an 18-
gauge needle was performed to conﬁrm the presence of the
ﬂuid before the start of the procedure. The incision was usually
along the mid-axillary line between the ﬁfth and sixth inter-
costal spaces.
With a scalpel, a vertical incision is made through the skin
and subcutaneous tissue, at the site previously chosen and
appropriate to the size of the trocar to be used, then proceed-
ing to blunt dissection of subcutaneous tissue and the inter-
costal muscles with curved artery forceps.
The entire pleural surface should be inspected in a system-
atic fashion including the parietal pleura of the chest wall, dia-
phragm, lung, mediastinum, heart, and vascular structures.
Biopsy was typically performed under direct vision using the
optical biopsy forceps inserted via the original port. A lateral
‘lift and peel’ technique was used, this technique produces ade-
quately sized biopsies. Many biopsies were taken and placed in
formalin for histopathology and in saline for culture, particu-
larly for TB.Statistical analysis
Statistical presentation and analysis of the present study was
conducted, using the mean, standard deviation and chi-
square test by SPSS V. 20 and P< 0.05 accepted to be
signiﬁcant.
Results
Table 1 shows the characteristics of patients in the two groups.
Regarding clinical presentations in group I; dyspnea was found
in 15 patients (75%), chest pain in 5 patients (25%), cough in
12 patients (60%), fever in 2 patients (10%) and haemoptysis
in 4 patients (20%). In group II; dyspnea was found in 8
patients (40%), chest pain in 7 patients (35%), cough in 9
patients (45%), haemoptysis in 1 patient (5%) but there was
no patient complained of fever. There was no signiﬁcant statis-
tical difference between two studied groups regarding clinical
presentations (P> 0.05).
Radiological presentations in group I were pleural effusion
with pleural based mass in 2 patients (10%), pleural effusion
with pleural thickening in 1 patient (5%), pleural thickening
only in 6 patients (30%), pleural mass only in 9 patients
(45%) and pleural nodules only in 2 patients (10%). While
in group II; pleural effusion only was found in 9 patients
(45%), pleural effusion with pleural based mass in 1 patient
(5%), pleural effusion with underlying collapse in 7 patients
(35%) and pleural effusion with pleural thickening in 3
patients (15%) (Figs. 1 and 2).
Pleural ﬂuid analysis was done for all patients presented
with pleural effusion and sent for chemical, bacteriological
and cytological analysis. No signiﬁcant statistical difference
was found between two studied groups as regards pleural ﬂuid
analysis (Table 2).
Complications of the procedures were in the form of pain at
the site of biopsy which was present in 2 patients (10%) in
group I and 4 patients (20%) in group II, Hemoptysis in 1
patient (5%) in group I, while in group II, no cases were
detected. Failure of the lung to expand was not detected in
any patient in group I while in group II, 5 patients (25%) were
Figure 1 CT chest (mediastinal window) demonstrating right
circumferential pleural thickening with ﬂuid density obliterating
right hemithorax with partial underlying lung collapse toward the
hilum.
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group I while in group II; 5 patients (25%) were detected. 3
cases out of 5 responded to oxygen inhalation via face mask
while 2 cases did not respond because of extensive adhesions
in one case and mesothelioma in the other case. Wound infec-
tion was not present in any patient in group I while in group II,
3 patients (15%) were detected (Table 3).Figure 2 Ultrasound image of a case of undiagnosed pleural
effusion with underlying pleural lesions during biopsy taking.
Table 2 Characteristics of pleural ﬂuid in the two groups.
Group I
Mean ± SD M
Protein 5.233 ± 0.462 8.
Glucose 111.667 ± 35.642 127.
LDH 479.667 ± 184.825 610.
ADA 17.833 ± 14.886 19.Follow up of patients after US guided pleural needle biopsy and
medical thoracoscopy (Table 4)
Oxygen saturation: was recorded using pulse oximetry.
Length of hospital stay: calculated from the day of perform-
ing the procedure to the day of discharge from hospital.
Chest X ray presentations: chest X ray was done for all
patients one day after the procedure. The ﬁnal histopatholog-
ical diagnosis presented in Table 5 shows that signiﬁcant statis-
tical difference between two studied groups in cases of pleural
tuberculosis and parapneumonic effusion (P< 0.05).
The sensitivity of ultrasound guided needle pleural biopsy
in diagnosis of pleural lesions was 85% as 17 out of 20 cases
were diagnosed by ultrasound guided pleural biopsy. While
the diagnostic sensitivity of medical thoracoscopy was 95%
as 19 cases out of 20 cases were diagnosed by medical thora-
coscopy with no signiﬁcant statistical difference between the
two procedures (P> 0.05).
Discussion
The present study aimed to compare safety and efﬁcacy of
medical thoracoscopic versus ultrasound guided transthoracic
needle biopsy in the diagnosis of pleural lesions. In this study,
we have presented the data of 40 patients who were divided
into two groups. Group I (20 patients) in whom Tru-cut needle
biopsy was performed guided by ultrasonography for the diag-
nosis of pleural lesions and group II (20 patients) who under-
went thoracoscopy for the diagnosis of undiagnosed pleural
lesions.
Exudative pleural effusions are frequently encountered in
pulmonary practice. Determination of a speciﬁc diagnosis
can represent a major challenge. Thoracoscopy is the investiga-
tion of choice in exudative pleural effusions where a diagnostic
pleural aspiration is inconclusive and malignancy is suspected
[8].
The clinical ﬁndings in this study were consistent with Sahn
et al. [9] who found that shortness of breath and chest pain
were the most common symptoms in pleural effusion. Also,
Dhital et al. [10] reported that the most common clinical symp-
toms were in the form of shortness of breath (83%), cough
(67%) and fever (66%).
In this study, regarding radiological presentations it was
noticed that in group I, pleural effusion only was not found
in any case while in group II, pleural effusion only was present
in 9 cases this means that patients with pleural effusion only
were not eligible for ultrasound guided pleural needle biopsy
due to the absence of pleural thickening or nodules for biopsy
taking but they were highly eligible for medical thoracoscopy.
This is in agreement with Kamel and Kaffas [11] who foundGroup II
ean ± SD
t P
215 ± 11.962 0.423 0.676
200 ± 59.371 0.436 0.667
385 ± 354.028 0.618 0.543
680 ± 10.531 0.271 0.789
Table 3 Complications of the procedures in the two studied
groups.
Complications Group I
n (%)
Group II
n (%)
X2 P
Failure to expand 0 5 (25%) 7.648 0.006*
Pain at the site of
biopsy
2 (10%) 4 (20%) 0.797 0.372
Wound infection 0 3 (15%) 4.402 0.036*
Pneumothorax 0 5 (25%) 7.648 0.006*
Hemoptysis 1 (5%) 0 1.412 0.235
* P< 0.05, X2: Chi-square.
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of pleural effusion only due to the absence of pleural thickness,
nodulation or masses.
In the present study, it was found that thoracoscopic
appearances were mostly conﬁrmed histologically, as the pres-
ence of nodules mostly indicates malignancy, while diffuse
thickening, adhesions and plaques suggest tuberculosis or
other inﬂammatory pleural affections. Histopathological diag-
nosis was matched with the gross appearance in some studies
[12–14]. However, they deﬁnitely need biopsies and
histopathological diagnosis. Another study reported that tho-
racoscopic appearances were not reliable, and that it was dan-
ger to rely upon inspection of the pleura alone without biopsies
[15].
On reporting complications of the procedures in this study,
pneumothorax was detected in 5 patients (25%) of group II
while not detected in group I. Three cases out of 5 cases
responded to oxygen inhalation via face mask while 2 cases
did not respond because of extensive adhesions in one case
and mesothelioma in the other case.
In agreement with this study Benamore et al. [16] reported
that the rate of new pneumothorax detected by chest radiogra-
phy was 4.7% in cases that underwent medical thoracoscopy
and complications were encountered in 25% of patients.
Diacon et al. [17] found that 3 (3%) patients had pneu-
mothorax relieved by chest tube insertion, 1 (1%) patient with
a small wound required a single suture, 1 (1%) patient devel-
oped dyspnea relieved by bronchodilators, minor events were
transient pain requiring medication in 5 (5%) patients, mild
and transitory haemoptysis in 2 patients (2%) and vasovagal
reaction in 2 patients (2%). In contrast to our results; someTable 4 Follow up of patients in the two groups.
Follow up of patients Grou
Oxygen saturation
Mean ± SD
94.54
Length of hospital stay in days
Mean ± SD
4.25 ±
Chest X ray presentations Pneumothorax n (%) 0
Collapsed lung n (%) 0
* P< 0.05,
t t test,
x Chi-square.studies [18,19] conducted using ultrasound guided pleural
biopsies found that the pneumothorax was the common com-
plication in their studies.
Some investigators [18] found that the total number of
diagnosed cases using ultrasound guided pleural biopsies was
24 (80%); 9 cases as mesothelioma (30%), 8 as bronchogenic
carcinoma with pleural metastasis (7 adenocarcinoma, 1 large
cell carcinoma), tuberculous effusion in 2 cases (6.7%),
inﬂammatory lung masses in 3 cases (10%), para-pneumonic
effusion in 2 cases (6.7%) and 6 cases were not diagnosed
(20%).
In our study, it could not be accessible to obtain biopsies
from 3 patients (15%) in group I. This may be due to that
the lesions were in contact with the chest wall for less than
1 cm regardless of their size and location, location behind a
rib was considered to be a contraindication, also in small
lesions <20 mm or in pleural effusion without underlying
pleural masses it was difﬁcult with a high failure rate in taking
the biopsy. In-group II, unfortunately it could not be accessi-
ble to obtain biopsies from 1 patient (5%) of all the studied
patients; this is because of the presence of extensive adhesions.
In agreement to these results Francois et al. [20] performed
diagnostic thoracoscopy in 149 cases and reported failure to
reach the diagnosis in 10 cases (6.8%). They explained this fail-
ure by the presence of extensive pleural adhesions that limited
the access to the pleural cavity. Sophie and Robin [21]
described failure to obtain biopsies in 3 cases out of 50 cases
(6%) during medical thoracoscopy due to either extensive
pleural adhesions or lack of any pleural abnormality during
thoracoscopy.
In this study, the sensitivity of ultrasound guided pleural
needle biopsy and medical thoracoscopy for diagnosis of cases
was 85% and 95% for groups I and II respectively. Adams and
Gleeson [22] reported that the overall accuracy of percuta-
neous image guided biopsy was about 91%, which means that
thoracoscopic biopsies may be superior to sonographic guided
Tru-cut biopsies.
As the sensitivity of diagnostic thoracoscopy in this study
was 95%, it indicates a high diagnostic yield of medical thora-
coscopy. The diagnostic sensitivity in previous thoracoscopic
studies varied from 66% to 100% [21,23–24].
There was partial agreement between this study and Kamel
and Kaffas [11] study as they found that the mean diagnostic
sensitivity of thoracoscopy was from 96.7% to 100%, and that
of ultrasound guided pleural biopsy was 65%.p I n (%) Group II n (%) X2 or t P
± 2.44 95.44 ± 1.88 1.307t 0.199
3.83 7.40 ± 4.90 2.265t 0.029*
5 (25%) 5.991x 0.014*
1 (5%) 1.412x 0.235
Table 5 Comparison between the two studied groups regard-
ing ﬁnal histopathological diagnosis.
Histopathological diagnosis Group I
(n)%
Group II
(n)%
X2 P
Pleural TB 0 4 (20%) 5.991 0.014*
Parapneumonic eﬀusion 3 (15%) 0 (0%) 4.402 0.036*
Inﬂammatory lung lesion 1 (5%) 2 (10%) 0.367 0.545
Pleural ﬁbroma 2 (10%) 0 2.878 0.090
Malignant mesothelioma 4 (20%) 6 (30%) 0.536 0.464
Sarcoma 1 (5%) 0 1.412 0.235
Adenocarcinoma 1 (5%) 5 (25%)
2.50 0.113
Squamous cell carcinoma 4 (20%) 0
Small cell lung cancer 0 0 0.000 1.000
Metastatic adenocarcinoma
(other than lung)
1 (5%) 2 (10%) 0.367 0.545
Undiagnosed cases 3 (15%) 1 (5%) 1.158 0.282
* P< 0.05, X2 = chi-square.
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value of medical thoracoscopy was 81.25%, another study
[26] found that thoracoscopy had a diagnostic value of 86%
in pleuropulmonary diseases.
Some authors who reported that thoracoscopy is a diagnos-
tic procedure for pleural cavity related diseases with 92–97%
sensitivity and 99% speciﬁcity and these results were in agree-
ment with the results of this study [27].
Also, thoracoscopy has the disadvantage of requiring gen-
eral anesthesia or sedation, requiring chest tube drainage and
inpatient stay, having the potential of failure due to adhesions
preventing pneumothorax, being substantially more expensive
than image-guided biopsy, and having a higher complication
rate [13,28]. Some authors have also shown that it is safe to
biopsy the pleura with the Tru-cut needle under ultrasound
guidance in situations in which the pleura is thickened and
when the pleural effusion is small in amount or loculated
[22]. Nithya et al. [29] concluded that medical thoracoscopy
is a better diagnostic tool in the hands of pulmonologists in
cases of undiagnosed exudative pleural effusions.
Conclusions
Medical thoracoscopy is an important diagnostic method for
the diagnosis of undiagnosed exudative pleural effusion but
with minimal or no role in cases of thickened pleura without
pleural effusion. Ultrasound guided needle pleural biopsy
may be helpful in cases of thickened pleura in the absence of
pleural effusion. It is concluded that US is more useful in cases
of pleural lesions without pleural effusion.
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